CS Paper Radar

CurvFlow-DTA: dual-graph discrete Ricci curvature flow for drug--target affinity prediction

Jicheng Ma, Yunyan Yang, Juan Zhao, Liang Zhao

cs.LG math.DG ·submitted 2026-09-19 08:02 UTC · v1

Abstract

Graph neural networks are widely used for drug--target affinity (DTA) prediction, and discrete Ricci curvature has recently been used to characterize molecular graph geometry. Existing curvature-aware DTA approaches mainly use static curvature on the drug graph while representing proteins primarily with sequence-derived features. This leaves pair-adaptive use of graph geometry underexplored, which may limit adaptation to unseen entities in cold-start settings relevant to practical screening. We present CurvFlow-DTA, which replaces a single static curvature representation with weighted Forman curvature flow on both molecular and protein residue--residue contact graphs. A label-independent flow trajectory is precomputed for each entity, and a pair-conditioned selector determines the horizons read by a dual-branch Flow-GINE. A frozen ESM-2 supplies residue-level representations and contact scores used to construct the protein graph. Inference requires only SMILES strings and protein sequences, without a bound complex structure. On Davis and KIBA, CurvFlow-DTA improves on the protocol-matched Ricci-GraphDTA baseline in every warm and cold-start setting. Warm-split mean squared error (MSE) decreases by $19.9\%$ on Davis and $18.9\%$ on KIBA. Across the six cold-start comparisons, MSE decreases by $14.3$--$27.4\%$, with higher concordance index (CI) throughout. Within our compiled set of literature baselines, CurvFlow-DTA achieves the lowest MSE on both warm benchmarks and across four out of six cold-start evaluation settings.

Closest papers

Nearest neighbours by meaning across the whole index.

When Does Discrete Ricci Curvature Help? An Edge-Level Analysis of Curvature-Enhanced GCNs for PPI Prediction

cs.LG ·2026-11-16 ·Clara Joswig, Elham Gholamzadeh, Ghazal Mostofi, Nico Scherf
published similarity 0.70
Abstract · 15 pages, 6 figures, 9 tables. Accepted at the NeurIPS 2026 Workshop on Geometric Distributional Deep Learning

Curvature-enhanced graph convolutional networks (CGCN) incorporate Ollivier-Ricci curvature (ORC), grounded in optimal transport theory, into message passing, motivated by the claim that curvature-weighted edges alleviate "over-squashing" at structural bottlenecks. But does CGCN's improvement actually come from mitigating over-squashing? We investigate this on four real-world protein-protein interaction (PPI) datasets, comparing CGCN against a standard GCN at the level of individual edges rather than aggregate metrics alone. While CGCN improves aggregate AUC, AUPR, and F1 across all four datasets, this gain is concentrated almost entirely on low-degree edges, while performance on low-curvature (bottleneck) edges systematically degrades in three of four datasets, the opposite of what the over-squashing motivation predicts. Examining the learned edge-weight function directly, together with clustering-validity metrics, edge-distance ratios, and a layer-depth ablation across four depths, we find evidence for an alternative account: curvature-weighting sharpens the separation between clusters, which improves intra-cluster predictions at the cost of inter-cluster (bottleneck) ones. We test this account against topologically defined communities rather than the classification labels used elsewhere. Additionally, we offer practical guidance on when to prefer CGCN over standard GCN, depending on whether intra- or inter-cluster predictions matter most.

0.35

HierDTA: Hierarchical Structure-Aware Representation Learning for Drug--Target Affinity Prediction

cs.LG cs.AI ·2026-10-19 ·Huangchao Xu, Baohua Zhang, Qian Liu, Zhong Jin, Yi Du
published similarity 0.70
Abstract · 20 pages, 7 figures

Drug--target affinity (DTA) prediction plays an important role in computer-aided drug discovery, where reliable computational models can help prioritize compound--protein pairs before experimental validation. A key challenge in DTA prediction is to effectively mine multi-level molecular information from drug structures while accurately modeling the binding-site environment of target proteins. To address these issues, we introduce HierDTA, a hierarchical structure-aware framework for DTA prediction. \textcolor{black}{HierDTA represents each drug as an atom--motif heterogeneous graph and introduces an augmentation module that propagates functional-motif semantics to the corresponding atoms. For proteins, kinase-domain structures are converted into residue interaction graphs. The resulting atom and residue representations are integrated using cross-attention to capture pair-specific relationships, while molecule fingerprints and pretrained ESM-2 embeddings provide complementary global information. Compared with state-of-the-art methods, HierDTA achieves superior performance on the Davis dataset across all metrics and attains the highest \(r_m^2\) of 0.791 on KIBA. It also exhibits strong generalization under cold-start settings, particularly on KIBA, where MSE is reduced by 21.7\% in the unseen-protein scenario. Ablation study and interpretability analysis supported the contributions of the hierarchical augmentation and interaction components.} Case studies further showed that HierDTA provided early enrichment of candidate bioactive compounds. These results indicate that HierDTA is an effective framework for affinity prediction and target-specific virtual screening.

0.31

DPTM-DT: Dual-Pretrained Transformer Multitask Representation Learning for Drug-Target Prediction

cs.LG cs.AI ·2026-08-28 ·Ge Kong
code/data similarity 0.65
Abstract

Drug-target relation prediction supports candidate screening, drug repositioning, and mechanism analysis. Existing models often use incomplete drug or protein representations, model cross-modal interactions shallowly, or train affinity regression and interaction classification separately, although these tasks describe closely related views of the same drug-target pair. This paper presents DPTM-DT, a dual-pretrained Transformer framework for multitask drug-target prediction. DPTM-DT combines GROVER molecular graph embeddings, ESM protein language-model embeddings, and CTD physicochemical descriptors, then exchanges drug-target information through bidirectional cross-modal attention. A shared pair representation is used for continuous affinity regression, high-affinity binary classification, and six-level affinity classification. Experiments on Davis and KIBA cover random 80/20 and DeepDTA-style standard splits. On the random 80/20 split, DPTM-DT achieves MSE/CI values of 0.193/0.917 on Davis and 0.120/0.918 on KIBA. It also reports binary AUPR/MCC values of 0.727/0.654 and 0.798/0.689, and six-class Macro-F1/Top-2 values of 0.800/0.932 and 0.815/0.962 on Davis and KIBA, respectively. Across the reported regression, binary classification, and multiclass classification settings, DPTM-DT achieves the best overall performance among the compared methods. Results under the standard split show the same relative trend. Ablations indicate that dual target representation, gated fusion, and cross-modal attention each contribute to the final performance. Code and supplementary materials are available at: anonymous.4open.science/r/DPCM-DT-74E0.

0.26

Self-Supervised Pretraining of Molecular Graph Encoders with LeJEPA

cs.LG q-bio.QMstat.ML ·2026-09-02 ·Michał Kulczykowski, Rafał Łabędzki
similarity 0.65
Abstract

Self-supervised pretraining has transformed language and vision, but its value for molecular graph neural networks remains contested. We ask whether pretraining on a large unlabelled corpus improves molecular property prediction. We adapt LeJEPA, a predictor-free joint-embedding predictive architecture regularised by Sketched Isotropic Gaussian Regularisation (SIGReg), to molecular graphs, evaluating GPS and Chemprop-style D-MPNN encoders on the Wong et al. [1] antibiotic-activity dataset and ogbg-molhiv using a multi-seed, bootstrap-based protocol. Pretraining improves learned representations but does not robustly improve finetuning. A frozen probe on pretrained embeddings exceeds random initialisation on both tasks (ogbg-molhiv ROC-AUC 0.788 vs 0.665; +0.123), reaching the published self-supervised band, but this does not translate into finetuning gains. On the antibiotic scaffold split, a canonical partition is significant (delta AUPRC +0.041, p = 0.010), but the effect vanishes across five partitions (pooled +0.013, p = 0.095). Finetuning is null on the random split, ogbg-molhiv, and D-MPNN. The representational edge is nevertheless recoverable. Embeddings saturate at ~16-32 effective dimensions, whereas Morgan fingerprints improve to 1024 bits. At matched dimensionality, fingerprints lead validation (0.799 vs 0.782 at 128 dimensions) but trail shifted test scaffolds (0.759 vs 0.788). Truncating embeddings and combining them with a 1024-bit Morgan fingerprint raises ogbg-molhiv ROC-AUC from 0.805 to 0.832 (delta +0.027; 95% CI [+0.003, +0.054]; p = 0.014); an untrained encoder gains nothing (delta -0.003). Thus, pretraining supplies complementary information best realised through feature-level combination, while finetuning gains are weak and partition-dependent.

0.30

WEECFP-SuRGE: A Position-Aware Substructure Encoding Method for Molecular Property Prediction

cs.LG ·2026-09-04 ·Robert Epps
hot direction similarity 0.64
Abstract

Computational molecular property prediction requires representations that capture local chemistry, long-range interactions, and molecular topology. Conventional fingerprints provide efficient local substructure features, whereas learned graph and sequence models can represent broader context but often rely on pretraining or three-dimensional conformers. We introduce Wide Encoded Extended Connectivity Fingerprints (WEECFP) with Substructure Rotary Graph-distance Encoding (SuRGE), a tokenized hierarchical Morgan representation in which graph-distance-dependent rotations are applied at the input and within transformer self-attention. Across MoleculeNet and the Therapeutic Data Commons ADMET benchmarks, WEECFP-SuRGE is competitive with recent pretrained and geometry-aware methods without external pretraining or conformer generation. We also show that the rotated token representation remains structurally informative. A guided confirmed-handshake overlap procedure reconstructs the correct constitutional isomer for 92.6% of a 4,200-molecule self-library evaluation. Together, the predictive and reconstruction results indicate that WEECFP-SuRGE preserves local substructure identity while making relative topology available to the model.

0.23

SMILESGNN: Interpretable Clinical Toxicity Prediction via SMILES-Graph Cross-Attention Fusion

cs.LG cs.AI ·2026-09-23 ·Quang Minh Nguyen, Thuy Quynh Nguyen, Duc Minh Le, Ho Nhat Minh Nguyen, Thanh Long Dai Doan +1 more
published similarity 0.64
Abstract

Drug toxicity prediction is critical for reducing late-stage attrition in drug discovery, yet remains challenging due to severe class imbalance, scaffold-based generalization, and the clinical need for interpretable predictions. Single-modality approaches-SMILES Transformers or graph neural networks capture complementary aspects of molecular structure, while sequence-only models cannot directly provide graph-attributed explanations. We present SMILESGNN, a multimodal architecture that fuses a SMILES Transformer encoder and a GATv2 graph encoder via cross-attention, and SMILESGNN-PT, a variant using a ChemBERTa-2 pretrained backbone. The design retains an explicit graph branch within the predictive pipeline, supporting GNNExplainer-based analysis of substructures associated with toxic predictions. On ClinTox, SMILESGNN achieves AUC-ROC 0.987 and F1 0.906 with only 0.4M parameters, performing competitively with a strong SMILESTransformer and a larger ChemBERTa-2/GATv2 concat-fusion baseline. On Tox21 (12 tasks), SMILESGNN-PT obtains mean AUC-ROC 0.750, comparable to ChemBERTa-2 alone and the same-backbone concat-fusion baseline. Overall, the results suggest that cross-attention is a practical fusion alternative that preserves competitive predictive performance while enabling graph-based interpretability support.

0.25

ColdDDI: Evaluating Knowledge Utilization in Cold-Start Drug-Drug Interaction Prediction

cs.LG cs.CL ·2026-10-04 ·Jiheng Liang, Chen Zhao, Di Wu, Chenyang Bu, Yunpeng Hong +2 more
publishedbenchmarkcode/data similarity 0.63
Abstract · Accepted at NeurIPS 2026 (poster). Code: https://github.com/0217ljh/ColdDDI-NeurIPS2026

Cold-start drug-drug interaction (DDI) prediction tests whether models can identify clinically significant interactions for drugs without training-time interaction history. Existing benchmarks mostly report aggregate edge-prediction scores, leaving a key evaluation question unanswered: when models receive molecular, textual, or knowledge-graph (KG) evidence, do they actually use the evidence that pharmacologically supports the interaction? We introduce ColdDDI, a reconstructible diagnostic benchmark built from DrugBank 5.1.13, with 1,900 approved small-molecule drugs and 565,731 positive DDI pairs. ColdDDI evaluates pairs with zero, one, or two unseen drugs. It also annotates each interaction by whether it changes drug exposure or drug effect, and by whether the biomedical knowledge graph contains shared enzymes, transporters, or targets that can plausibly mediate the interaction. These annotations separate evidence availability from predictive dependence. We evaluate eight conventional DDI methods and 13 LLMs; for open-weight LLMs, we test five prompt patterns and use masking, drug replacement, and channel-sensitivity metrics to probe knowledge utilization. ColdDDI exposes that, in the hardest split where both drugs are unseen, the main performance divide is mediator availability. A fine-tuned 1B LLM recovers 89-93% of interactions with a shared enzyme, transporter, or target, but only 40-62% without such a mediator. More importantly, KG-provided evidence is not always used; several KG-augmented baselines change little when the shared mediator is masked or disrupted, whereas fine-tuned LLMs respond strongly to this intervention. Thus, ColdDDI evaluates knowledge utilization rather than knowledge access alone, showing where cold-start DDI models rely on mechanistic evidence and where they fail despite receiving it. Code is available at https://github.com/0217ljh/ColdDDI-NeurIPS2026.

0.39

Chemical and geometric representation fidelity improves drug--target affinity prediction

cs.AI q-bio.BMcs.LGstat.ML ·2026-09-02 ·Yixiao Li, Yining Qian, Yefan Chen, Zenghui Chen, Jiayue Sun +3 more
benchmark similarity 0.63
Abstract · 21 pages, 10 figures

Predicting drug--target binding affinity (DTA) requires models to distinguish subtle chemical and structural determinants underlying molecular recognition. Although recent approaches increasingly incorporate richer drug and protein information, such information may be compressed, homogenized or discretized during representation construction, causing affinity-relevant distinctions to be lost before interaction modelling. We hypothesized that this representation-stage information loss constitutes an upstream bottleneck that cannot be reliably overcome by increasingly complex interaction predictors. To test this hypothesis, we developed ReGeoDTA, a representation-preserving framework that maintains affinity-relevant chemical heterogeneity in molecular representations and continuous geometric relationships in protein structures. Across three benchmark datasets, ReGeoDTA consistently improved affinity prediction, and the proposed representation-preserving strategies retained their benefits across diverse DTA architectures. Controlled representation degradation progressively reduced predictive performance, whereas increasing downstream predictor complexity failed to recover information lost during representation construction. These findings identify representation fidelity as an upstream design principle for accurate and generalizable drug--target affinity prediction, with potential implications for computational compound prioritization.

0.23